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1. DNA repair systems  
Cells are continuously exposed to stressors that can mine the DNA integrity, forming cleavages or 
double strand breaks. This causes missed protein interactions regulating gene expression, DNA 
replication and other cellular processes. In addition, the single base modifications or mismatches 
that do not follow the Watson and Crick’s rules are dangerous for the DNA integrity. 
During evolution, cells have developed DNA repair systems. They start with DNA detection and the 
Cell cycle arrest until the repair. If the DNA lesion is too serious and the cell is unable to repair the 
damage, the only way to maintain the DNA integrity is driving the cell to apoptosis. 
Most DNA repair systems, share in general transcription factors as DNA helicase, replication 
factors, DNA polymerase and ligases. Also, if each DNA repair system is specific and able to 
recognize the single lesion, most of them can cooperate.  
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1. Direct repair (DR) 
2. Nucleotide excision repair (NER) 
3. Base excision repair  (BER) 
4. Mismatch repair (MMS) 
5. Double strand repair (DBS). 
 
1.1 Direct repair 
Direct repair is the simplest system and does not need the template to perform the repair. 
Bacteria and Yeast, for example, in a light-dependent reaction, restore directly the damage resulting 
from UV or cisplatin treatment with several photolyases (1). Surprisingly, even if there is no visible 
light in most tissue, photolyase binds to cisplatin-damaged DNA. This enzyme has also the ability 
to respond at oxidative stresses (2; 3).  
Only a few types of DNA damage are repaired with this system, such as pyrimidine dimers 
resulting from exposure to ultraviolet (UV) light and alkylated guanines that have been modified by 
the addition of methyl or ethyl groups at the O
6
 position of the purine ring. 
In this case, just one enzyme, O6-alkylguanine-DNA–alkyltransferase, transfers alkyl or methyl 
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work independently to other proteins and without breaks of DNA molecule. The DR is active also 




1.2 Nucleotide excision repair (NER) 
This system is certainly one of the most versatile mechanisms of DNA repair, it is able to identify 
and process bulky lesions and those that deform double helix, as cyclobutane dimers and 6–4 
photoproducts. 
Bacteria, yeast and human XP (Xeroderma Pigmentosum) syndrome cells are excellent models to 
study the NER system.  
In human, the NER system shows all its complexity and can be summarized into four stages: 
1. Damage recognition/preincision 
2. Incision 
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The damage recognition is assigned to the complex: replication protein A (RPA) and XPA and also 
transcription factors as IIH (TFIIH/XPB/ ERCC3, XPF-ERCC1 and XPG (5).  
The incision step is ATP-dependent, it reacts where the excinuclease complex at the 3’ and 5’ of the 
lesion. XPG, for example, cuts at 3’ while another nuclease; FEN (flap endonuclease) cuts at 5’ (5). 
The polymerases δ and ε start the synthesis of new nucleotide from free 3’OH extremity; while 
proliferating cell nuclear antigen (PCNA) is required to fill the gap.  
The NER is a multistep process, which involves more than 20 proteins. There are two principal 
pathways when NER is particularly active: 
-TCR-NER (transcription coupled repair) 
-GGR-NER  (global genome repair) 
The first pathway is a highly specific and efficient system, able to recognize and cut out the DNA 
damage arresting the RNA polymerase II progression. It is particularly sensitive to Cisplatin 
damages (6). 
GGR-NER deals with all repairable lesions throughout the genome; it shares the proteins involved 
in the initial recognition of lesions with TCR-NER system. In normal situations, the damage 
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activation of p53 tumor suppressor gene. This transactivation role controls gene expression, XPC 
and XPE, which are involved only in the GGR-NER (7).  
Two disorders are known to be deficient in NER system: XP and Cockayne syndrome. 
 
1.3 Mismatch repair (MMS) 
This strategy erases the mistakes that appear during DNA replication and in this particular case the 
mismatches, insertions/deletions of loops, deaminations of 5-methylcytosine to uracil mining the 
fidelity of DNA replication. The essential strategy of MMR is similar to the excision repair. In 
human, two pathways of mismatch repair have been identified: 
1. long-patch 
2. short-patch 
The first cuts large sequence but has no sequence specificity, while the Short-patch repair cuts just 
one or few nucleotides, keeping in mind the sequence context. 
The MMR system was well studied in E.coli (Escherichia coli). 
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During the initiation, MutS recognizes the mismatch and then in a reaction ATP-dependent Mut H 
interacts with the homodimer MutL. Mut H, now activated, cuts the nucleotide, erroneously inserted 
during synthesis. Mut H is able to identify the new strand because the adenine present in the GATC 
site is still not methylated. The DNA polymerase III holoenzyme and DNA ligase make 
respectively the resynthesis and the ligation (8). 
In human, six genes has been identified: hMSH2, hMSH3, hMSH6, hMLH1, hPMS1, and hPMS2. 
HMSH2, hMSH3 and hMSH6 are human homologs of E. coli MutS. In a reaction ATP-dependent, 
these enzymes bind to DNA heteroduplex and promote long-patch MMR. hMSH6, also called G/T 
mismatch binding protein,  is very efficient in recognizing G:T mismatches.  
Defects in hMLH1, hMSH2, hMSH6, hPMS1, and hPMS2 are associated with hereditary 
nonpolyposis colorectal cancer (HNPCC) (9; 10). 
 
1.4 Double strand break repair (DSBR)  
The double strand break is usually contemplated as the most lethal DNA lesion. Ionizing radiation 
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principal causes of this kind of disease. The double strand breaks are usually present when the 
replicative fork meet single breaks, when the same problem is present during the metabolism of 
telomeres (11; 12). 
The efficient repair of double strand breaks has a fundamental importance in maintaining genomic 
integrity, cellular viability and, obviously, in preventing tumorigenesis. 
Currently, three primary pathways are known: 
1. Homologous recombination repair, (HR) is prevalent during G2 phase and in dividing cells 
and a homologous sister chromatid, as template, must be present. MRE11, RAD50, and 
NBS1 form a complex able to recognize DSBs and to recruit the protein kinase, called ataxia 
telangectasia mutated (ATM), which is essential for the subsequent steps of the 
recombination process. 
2. Single strand annealing, more similar to HR. 
3. Non-homologous end joining repair, NHEJ is the leader during the G0/G1 cell cycle phase 
when a homologous sister chromatid is absent. NHEJ shows three main steps: (a) detection 
of the two-ended DSB, (b) process to remove the damage at the break and to expose short 
stretches of microhomology, and (c) join of two suitable ends (13). 
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Base excision repair is active in removing non-bulky base adducts such as those originated by 
oxidation, reduction, methylation or fragmentation of bases following oxidative damage or ionizing 
radiations. The BER enzymes are the first cellular mechanisms recruited to repair damaged DNA. 
This system is active during all stages of cell cycle both for dividing and non-dividing cells (13).  
This is a multistep organization that implicates several proteins. When the damage is identified, the 
glycosylases remove purines and pyrimidines from DNA, creating an apurinic or apyrimidinic, 
potentially cytotoxic, site known as AP site  (14). 
At this point, endonucleases  (APE1, APEX, REF-1) incise 3’ (AP lyase) and 5’(AP hydrolase) to 
the apurinic site. In the last step, DNA polymerases fill the gap and DNA ligase complete the repair 
action. 
The glycosylase enzymes can be classified in mono- or bifunctional enzymes in the matter of their 
mechanism. TDG (Thymidine DNA glycosylase), UDG (Uracil DNA glycosylase), SMUG and 
Med1/MBD4 are monofunctional glycosylase which cleave the glycosidic bond using water as a 
nucleophile to generate apurinic or apyrimidinic (AP) sites. They show specificity to repair 
deamination of C (cytosine) and or 5-meC (5-methycytosine) residues. The bifunctional DNA 
glycosylase uses an amino group of enzymes as a nucleophile to form a Schiff base intermediate, 
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abasic site. (15). BER is active during all cell cycle, and has a critical function in dividing and non-
dividing cells. 
 BER system can be summarized in 4 main stages: 
1. recognition and excision of an inappropriate base; 
2. incision and AP site formation; 
3.  replacement of the excised nucleotide; 
4. sealing of the final nick. 
Nowadays, it is known that defects in one or more components of BER system induce cancer 
predisposition as colorectal cancer (16). 
 
1.5.1 Med1/MBD4 
In 1999, Bellacosa and collaborators identified in yeast two-hybrid system Med1 as interactor of 
MLH1, a protein involved in the mismatch repair (17). This paper shows the structure of Med1 
which contains N-terminus, the methylcytosine binding domain, important for binding an N-
terminus to methylated DNA, while a C-terminal contains the catalytic domain presenting a strong 
homology with the systems of glycosidases and ligase that repair the damage to bacterial DNA. The 
central structure of the protein is still under investigation. 
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While DNA repair systems, such as NER and MMS, are more complicated, BER removes 
nitrogenous bases that carry specific injuries. For this purpose, a crucial role is played by the DNA 
N-glycosylase, which removes damaged bases or those involved in mismatch phenomena through 
the N-glycosidic bond cleavage. In its modus operandi, Med1/MBD4 inspects the CpG sites in the 
genome with its MBD domain. The deamination of 5-methylcytosine to thymine in CpG islands 
creates G: T mismatches that are processed by the catalytic domain of Med1. At this point, the 
glycosylase activity produces AP sites (apurinic or apyrimidinic sites) to which Med1 remains 
bound until the systems of polymerase and ligase will not restore the missing base. For this reason 
MED1/MBD4 is essential to safeguard genomic integrity in CpG sites. (18). 
The specificity of DNA-glycosylase enzymes is particular evident during the repair activity. In 
effect, the methyl binding domain protein 4 (MBD4/MED1) is very sensitive to act on G:IU 
(iododeoxyuridine) but not A:IU, while, the other DNA–glycosylase enzymes are not required to 
repair this mismatches. (19).  
It is also known that MED1/MBD4 shows a strong activity in repairing halogenated pyrimidines 
comparing top urine bases and is essential for the cytotoxicity of 5-iododeoxyuridine. (20.). 
The involvement of Med1/MBD4 in colorectal cancer and ovarian cancer is showed in the 
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 In addition, MED1 is very important in regulating the apoptosis of those cells highly damaged by 
diverse drugs, especially methylatin agents (23; 24). 
 
 
2.Post-translantional modification: SUMOylation 
Discovered in 1997, the SUMOylation has been the topic of numerous studies focused on 
understanding its role in different cellular processes such as transcription, replication, chromosome 
segregation and DNA repair (25; 26). 
This post-translation modification has been very often associated to the ubiquitination, because they 
share the structural conformation and the activation cycle.  Recent studies show SUMOylation as a 
link to the proteosome system. 
SUMO is ubiquitously expressed in all eukaryotes and is highly conserved. 
The invertebrates code just one gene for the protein SUMO, on the contrary, the vertebrates have 
showed three genes: SUMO1, SUMO2-3, and SUMO4.  
SUMO1, also known as UBL1, PIC1, sentrin, GMP1 and Smt3c, founding member of the family, is 
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ubiquitin. SUMO1 has been discovered as an interactor of Ran-GAP. Ran-GAP is a nuclear protein, 
but after its sumoylation becomes a cytoplasmatic protein (27). 
SUMO2, also called sentrin 2, Smt3b and GMP-related protein and SUMO3, also known as sentrin 
3 and Smt3a, considering their high homology of sequence, are usually associated in SUMO2-3. In 
effect, SUMO-2 and -3 differ from each other only by three residues at the N-terminal sequence. 
Both SUMO1 and SUMO2-3 are ubiquitously expressed. On the other hand, the expression of 
SUMO 4 is circumscribed to human brain, kidney, lymph node and spleen but it is very difficult to 
detect the endogenous SUMO4 protein. Its function is unclear as well as its activation cycle.  
 
2.1 The sumoylation cycle 
The SUMO proteins are synthesized in an inactive isoform. The isopeptidase, called SENPs, 
cleaves 4 amino acids (AA) for the SUMO1, 11 AA for SUMO2 and 2 AA for SUMO3. This cut 
shows the functional domain established with 2 glycines in the C-terminus of the proteins.  
At this point, in a reaction ATP-dependent, the SUMO adenilate SUMO is activated by E1, 
activating enzyme. This heterodimer presents two subunits: AOS1 and UBA2.  
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Consequently SUMO is transferred on a catalytic cysteine residue which is located on the second 
cofactor of the SUMOylation cycle, called E2, also know as UBC9, which has the purpose of 
transporting SUMO to its target protein and for this reason it is called conjugating. The final step is 
given by the formation of a peptide bond between the glycine residue of SUMO and a lysine residue 
of the target protein that is within an acceptor site, called consensus site, in which the lysine that 
makes contact with SUMO is flanked by AA aliphatic and by an Arginine. 
Sometime, the SUMOylation cycle requires the presence of another cofactor: E3 (ligase proteins). 
The role of this further component is to enhance the identification of the SUMO targets. Usually, 
the ligases help the overall SUMO-E2 to approach better the target protein. Recent studies also 
show a link between the presence of the cofactor E3 and the ubiquitin system and therefore of 
protein degradation. In the in vitro experiments, E3 can also be absent. 
The SUMOylation cycle relies on a single E1 and E2 enzymes and less of the E3 ligases; on the 
contrary, the ubiquitination pathway shows 10 E2 and 100 of different E3 (28). 
 
 
2.2 Consensus sites 
Most of target proteins of identified SUMO show an acceptor Lysine within a particular consensus 
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cooperates with the thioester complex E2-SUMO. A crucial role is shown in regulating the right 
interaction between the complex and the target protein. 
When the protein is SUMOylated, its consensus site undergoes a conformational change so that the 
acceptor Lysine finds a place in a hydrophobic pocket of UBC9. The electrostatic interactions and 
hydrogen bonds formed help the direct recognition of the consensus site (30). 
In the last years, an increasing number of studies showed the presence of particular amino acids 
near the consensus site. These amino acids can be phosphorylated creating the PDSMs 
(phosphorylation-dependent SUMO site). In this case, the amino acid is localized at the end of the 
consensus site: ψKX(D/E)XXSP. 
The negatively charged amino acids are present in the NDSMs sites (Negative charged amino acid 




2.3 Molecular consequences of SUMOylation 
Although SUMO is considered a direct relative of ubiquitin, actually the molecular consequences of 
the SUMOylation are profoundly different compared to those of the ubiquitination where direct 
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The Sumoylated proteins can change their activity and function. For example, the nuclear protein 
Ran-GAP, when SUMOylated changes its localization, becomes a cytoplasmic protein. 
In general, SUMOylation can have three essential molecular effects: 
1)  it can interfere in the interaction between a target and its partner, and in this case, the 
interaction is allowed in the absence of SUMO; 
2) it may provide a binding site for an interaction partner showing interaction sites and non-
covalent binding sites  of SUMO, indicated with the acronym SIM / SBM; 
3) it can give life to a conformational change of its target that can modify the protein activity. 
The third effect is particularly important in the BER system since in 2002, Primo Schar showed for 
the first time, the link exiting between the human Thymidine DNA Glycosylase (hTDG) and the 
SUMOylation reaction. In his work, P. Schar proved that SUMOylation induces a conformational 
change in hTDG, which increases the turnover of enzyme. This effect seems common to the other 
BER enzyme (31). 
 
2.4 BER system and SUMOylation 
The DNA harbored in the eukariotic cells is continuously stressed by oxidative damage for 
endogenous or exogenous mechanisms. The first DNA repair system involved in the repair of this 
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primary response to execute an appropriate repair response. For this reason, the SUMOylation that 
can change the protein localization is very important to regulate this process.  For example, Ntg1 
and Ntg 2 are N-glycosylase andAP/ ligases present in Saccharomyces cerevisiae. Ntg1 is identified 
in nuclei but also in mitochondria, on the contrary, the localization of Ntg 2 is just nuclear. After an 
increase of nuclear and mitochondrial, Ntg1 is found to be more present in the nucleus compared to 
the mitochondria. 
Contrariwise, Ntg 2 remains a nuclear localization even following oxidative stress. (32). The 
SUMOylation plays a central role in determining the transit between nuclei and mitochondria. In 
effect, high SUMoylated Ntg1 accumulates in the nucleus following the oxidative stress. 
SUMOylation, as previously described, is also important to increase the turnover of BER enzymes. 
For example, after SUMOylation, hTDG changes its conformational structure that involves its 
flexible N-terminus and as a consequence loses the ability to bind the DNA (33; 34). Interestingly, 
TDG has also been shown to interact with transcription factors, as Jun, suggesting a link between 
transcription and BER. TDG is also an interactor of transcriptional coactivators CREB-binding 
protein (CBP) and p300. They enhance different transcription factors, signaling pathways. When 
TDG is SUMOylated, it loses the ability to interact with this complex (35). 
Moreover, XPC complex, which is a DNA damage detector for NER, is able to stimulate the 
activities of sumoylated TDG and in this case, the enzyme in its SUMOylated form acquires the 
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changes its conformational structure involving its flexible N-terminus and as a consequence it loses 
the ability to bind the DNA (37; 38). 
Considering the consistent information about SUMOylated TDG, its consequences and the poor 
knowledge about the role of SUMOylation for MED1/MBD4, this thesis has been developed to 
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2.1Cell line and Cell culture 
The cells used in this work are MCF7, human breast carcinoma. These cells were cultured in 
DMEM high glucose supplemented with 10% FBS, 2mM L-Glutamine, 0.1 mM non-essential 
amino acids, 1mM Sodium Pyruvate, 0.01mg/ml Bovine Insulin, 100um/ml Penicillin and 100 
Units/ml Streptomycin. Cells were grown at 37 C in 5% of humidity. 
 
2.2Transfection  
Cells were plated in 10 mm Petri dishes, 2.4 x 10
5
 cells to obtain 80% of confluence. The 
transfection was carried out using 10 ug of plasmid DNA, 20 uL of Lipofectamine 2000 
(Invitrogene) and Optimem (GIBCO). 
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Cells and all buffers were maintained on ice to minimize the protein degradation and enzyme 
denaturation. MCF7 were washed three times with cold PBS (Phosphate buffered Saline) and then 
the lysis was performed with cold RIPA buffer supplemented with 10 mM NEM (N-
ethylmaleimide, Sigma), 1:100 PMSF (Phenyl methane sulfonyl fluoride), 1:100 NaVO4 (Sodium 
ortho-vanadate), 1:100NaPP (Sodium pyrophosphate), 1:1000 PI (Protease Inhibitor), 1:1000 DTT 
(Dithiothreitol) for 30 minutes on ice. Cells were scraped off the dish and sonicated for 30 seconds. 




The protein concentration was identified using Bradford assay (Biorad) and BCA assay (Thermo 
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The immune-blotting analysis was performed using 500 ug of protein lysate in 400 uL of RIPA 
incomplete buffer. For each protein lysate, 3 uL of T7-tag antibody (By Novagene) were added and 
incubated for 3 hours at 4°C. After that, 20 uL of A/G beads (by Thermo Scientific) were added for 
2 hours at 4°C. 
At the end, the mix was gently spun, and the supernatant was discarded. The beads were washed 
with incomplete buffer for three times. 
To the Co-immunoprecipitated, 40 uL of Laemly Buffer (By Novex) were added without reducing 
agent and it was boiled for 10’. 
 
2.6 Immunoblotting 
Immunoblotting was performed using polyacrylamide gels (4-12%), MOPS buffer and protein 
marker (byNovex). The run was carried out at 150 V for 2 hours and half. The amount of loaded 
protein was 50 ug each time. Before the transfer step, the PVDF membrane, was hydrated with 
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(Stock: 12.5 X - TRIS-BASE 37.5g, glycine 18g, 1 L of dH2O). After one hour of transfer, the 
membrane was incubated in 5 % milk and TBS-T 0.1%.  
The primary antibodies were incubated in 2% milk and TBS-T 0.1 %(Anti-T7 tag, mouse, 1:2500 
by-Novagene, Anti-HA tag, rabbit, 1:5000 by Cell Signaling) over night at 4°C.  After three washes 
with TBS-T 0.1%, the membrane was incubated with secondary antibody (goat anti-mouse and goat 
anti-rabbit by Santa Cruz, 1:4000) in 2% milk and TBS-T 0.1% and developed with ECL system by 
Pierce. 
 
2.7 Drugs treatment 
Methyl-N-nitrosurea (MNU) or Cisplatin were dissolved in DMSO at the final concentration of 
10/mg/mL. 24 hours after the transfection, cells were  treated  with  MNU or Cisplatin (2 uM).  
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In order to evaluate the localization, two assays have been performed using commercial kits. 
The first assay was performed following the manufacturer’s instructions of Nucbuster Protein 
Extraction Kit by Millipore. The second assay was carried out using Subcellular Protein 
Fractionation Kit for Cultured Cells by Thermo Scientific. 
 
 
2.9 In Silico analysis 
Using the free software SUMO plot, it was possible to identify three main sites for covalent 
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3.1 Interaction between Med1/MBD4 and hSUMO1 
 
In order to verify the possible interaction between the enzyme of the DNA repair, Med1/MBD4 and 
hSUMO1, a Co-immunoprecipitation was performed.  
MCF7 cells were transfected with the following plasmids: 
-the wild-type Med1/MBD4 with the HA tag 
-the isoform of Med1/MBD4, mutated in three main sites of covalent sumoylation, combined with 
the HA tag: 
- hSUMO1 associated with the wild-type T7 tag.  
As shown in Figure 3.1, Med1/MBD4 interacts with hSUMO1. The band of SUMOylated enzyme 
is visible around 70 kDa. The mutated isoform of the same enzyme exhibits bands of 
poliSUMoylation, which are still under study. The first band is always around 70 KDa but the oneof 
puliSUMOylation is situated around 100 KDa. 
The western-blots (Figure 3.2) confirmed  the correct transfection. The HA tag is identifiable in the 
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2: HA-Med1/MBD4 wt; 
3: HA-Med1/MBD4 mut 1-2-3; 
4: HA-Med1/MBD4 wt + T7-hSUMO1; 
5: HA-Med1/MBD4 mut 1-2-3 + T7-hSUMO1. 
In lines 4 and 5 numerous bands of poliSUMOylation are encountered, up to 110  KDa until 160 
Kda.  
The Beta-actin  (Fig. 3.3) shows the same amount of loaded proteins. 






Fig. 3.1: Co-IP Med1/MBD4 and hSUMO1
The Co-IP shows the interaction between Med1/MBD4 and hSUMO1 (line 4 : wild-type isoform of 
Med1/MBD4 + hSUMO1; line 5:  mutated isoform of Med1/MBD4 + hSUMO1; controls: line 1 : 
untransfected; line 2: Med1/MBD4 wild-type; line 3: mutated Med1/MBD4)
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3.2 Interaction between Med1/MBD4 and hSUMO1 after Cisplatin treatment 
 
Having determined the possibility of Med1/MBD4 of being SUMOylated, the second step was to 
verify whether the treatment with cisplatin, drug that intercalates DNA and moreover commonly 
used in clinic as chemotherapeutic, could influence the SUMOylation of Med1/MBD4.  
Treatment with cisplatin was performed at 24 hours after transfection; the dose administered was 
2uM. 
The Co - IP, (fig. 3.4), showed a really interesting figure, in fact while in line 4 (corresponding to 
HA-Med1/MBD4 wt + T7- SUMO1) the sumoylation band remains around 70 kDa, in line 5 
(corresponding to HA-Med1/MBD4 mut 1-2-3 + T7- hSUMO1), sumoylation bands are no longer 
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The WB (Fig. 3.5) showed the expression of both isoforms; wild-type and mutated in the three main 
sumoylation sites, but the bands of poliSUMOylation are completely missing.  
In WB with HA ab, the SUMOylation bands are absent while the WB with T7-tag continues to be 
visible. 




1 - 2 - 3 - 4  - 5
2uM of Cisplatinum 24h after the transfection
Fig. 3.4 : Co-IP Med1/MBD4 and hSUMO1 after Cisplatin treatment
The  interaction between Med1/MBD4 and hSUMO1  remain with wild-type isoform of 
Med1/MBD4 + hSUMO1 (line 4) but is lost with mutated isoform of Med1/MBD4 + hSUMO1 
(line 5); controls: line 1 : untransfected; line 2: Med1/MBD4 wild-type; line 3: mutated
Med1/MBD4)
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3.3 Interaction between Med1/MBD4 and hSUMO1 after MNU treatment 
 
With the intent to stress the ability to repair, Med1/MBD4, MCF7 cells were treated 24 hours after 
transfection with the alkylating agent, MNU, N-methyl-N-nitrosourea at concentration of 2uM. 
As already observed with cisplatin, the treatment with MNU displayed a total loss of interaction 
betweenMed1/MBD4 mutated in the three main sites of SUMOylation and hSUMO1. However, the 
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WB (Fig. 3.8) showed the expression ofMed1/MBD4 and emphasized poliSUMOylation bands for 
both Med1/MBD4wild-type and its mutated isoform. 
The Beta-actin (3.9) was used as control of the amount of loaded protein. 






Fig. 3.7: Co-IP Med1/MBD4 and hSUMO1 after MNU treatment
The Co-IP shows again the interaction between Med1/MBD4 and hSUMO1 (line 4 : wild-type
isoform of Med1/MBD4 + hSUMO1; the mutated isoform of Med1/MBD4 + hSUMO1(line 5) is
absent; controls: line 1 : untransfected; line 2: Med1/MBD4 wild-type; line 3: mutated
Med1/MBD4)
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The sumoylation is a post-translational modification that alters the activity of its target protein. 
The purpose of the glycosylase assay was to check whether changes are detected in Med1/MBD4 
after SUMOylation activity. 
The experiments were precisely made with the help of Genomic Facility of the Fox Chase Cancer 
Center. 
Each assay had planned time using nuclear extracts, obtained with the Nucbuster kit by Millipore, 
respectively oligonucleotides containing mismatches G:Uand G:Tand the APE enzyme 
(endonuclease). 
The results of glycosylase activity showed a strong propensity to repair the sumoylated isoform 
Med1/MBD4, which changed in the three main sites of covalent SUMOylation. This isoform has 
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HA-MED1 mut 1-2-3+T7 SUMO
Fig. 3.10 : Glycosylase activity
a) oligo G:T; b) oligo G:U. The assay shows a strong activity for
SUMOylated Med1/MBD4 mutated and higher affinity for the repair of 
G:T mismatch than G:U
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3.5 Interaction between Med1/MBD4 and hSUMO1: localization 
When discovered for the first time, the sumoylation was considered the post translational 
modification capable of migrating protein Ran-GAP to the cytoplasm from the nucleus (Melchior 
1999). In order to study the possible changes in location of Med1/MBD4 after sumoylation we used 
two commercial kits: Nucbuster by Millipore and Subfractionation for cultured cells by Thermo 
Scientific. 
The first kit showed that protein Med1/MBD4, despite being a protein in nuclear localization, when 
SUMOylated has also the ability to translocate into the cytoplasm. The cytoplasmic localization was 
observed in both isoforms, wild-type and in the mutant enzyme (Fig. 3.11; 3.12). 
The kit of Thermo Scientific allows the separation of the proteins present in different nuclear 
compartments such as: 
- membrane proteins 
- fraction of cytoplasmic proteins 
- nuclear extracts 
- cytoskeletal proteins 
- chromatin 
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Fig. 3.11: WB  (with HA ab by Cell Signaling) of total lysates extracted with Subcellular 




3 HA-MED1 mut 1-2-3
4 HA-MED1 wt + T7-SUMO1

















1 2 3 4 5





3 HA-MED1 mut 1-2-3
4 HA-MED1 wt + T7-SUMO1
5 HA-MED1 mut 1-2-3 +T7-SUMO1
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Fig. 3.12: WB  (with T7  ab by Novagene) of total lysates extracted with Subcellular Protein 
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The results confirmed those obtained with the Nucbuster kit. In fact, the sumoylated Med1/MBD4 
was found both in the cytoplasmic fraction and in the membrane proteins and of course in the 




3 HA-MED1 mut 1-2-3 NUCLEAR extracts
4 HA-MED1 wt + T7-SUMO1
5 HA-MED1 mut 1-2-3 +T7-SUMO1
6 HA-MED1 wt
7 HA-MED1 mut 1-2-3
8 HA-MED1 wt + T7-SUMO1 CYTOPLASMIC extracts
9 HA-MED1 mut 1-2-3 +T7-SUMO1
10 not transfected
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3 HA-MED1 mut 1-2-3 CYTOPLASMIC extracts
4 HA-MED1 wt + T7-SUMO1
5 HA-MED1 mut 1-2-3 +T7-SUMO1
6 HA-MED1 wt
7 HA-MED1 mut 1-2-3
8 HA-MED1 wt + T7-SUMO1 NUCLEAR extracts
9 HA-MED1 mut 1-2-3 +T7-SUMO1
10 not transfected
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The SUMOylation has aroused great interest in science, precisely because this post-translational 
modification is able to adjust the complex cellular metabolism, intervening on activity, localization 
and stability of target proteins. 
The great excitement around the SUMOylation concerns the proteins involved in DNA repair. The 
increased knowledge on the consequences of the modification of enzymes involved in DNA repair 
may provide useful tools not only for basic research, but also for translational research, especially in 
oncology. 
This work was born from the desire of investigating the effects of SUMOylation of the enzyme 
involved in DNA repair system of the BER: Med1/MBD4. 
Using the SUMOplot software, it was possible to identify 3 main sites of covalent sumoylation, 
K137 – 215-377 and replace them with R. 
The rate of Co -immunoprecipitation showed the ability to interact with Med1/MBD4 hSUMO1. 
Surprisingly, the interaction remains the same even when you change the three main sites of 
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The interaction was also verified, following treatment ofMCF7 cells, with agents responsible of 
causing DNA damage as MNU or Cisplatin. Co-immunoprecipitation assays, also in this case, have 
shown that the interaction between Med1/MBD4 hSUMO1remains unchanged for the wild-type 
isoform of the protein, whereas it is completely absent in regards to the mutated isoform. 
These findings suggest that for the sumoylation of Med1/MBD4, non-covalent sumoylation sites are 
mainly involved. 
Further experiments were aimed to clarify the possible changes in activity and localization of 
Med1/MBD4 after sumoylation. 
The glycosylase assays showed in this regard a strongly mutated isoform activity of Med1/MBD4 
sumoylated in the repair, with a particular propensity to shelter the oligo G:T than G:U. 
These data suggest that sumoylation of Med1/MBD4 imparts a strong enzyme repairing activity, 
especially highlighted in the specificity in the restoration of the oligo G:T. 
The experiments have shed light on the location of a change in the protein which sumoylated from 
native nuclear, it also becomes cytoplasmic. 
Future studies will be focused on a careful analysis of the sites of sumoylation of non-covalent 
Med1/MBD4, it will be also studied the biological significance of the change of location and 
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